Author: Benton Bodamer

[ad_1] Would a Schedule III Reclassification of Psychoactive Cannabis Help or Hurt State Operators? By Benton Bodamer, Member, Dickinson Wright PLLC, Adjunct Professor of Law, Drug Enforcement and Policy Center, Moritz College of Law, The Ohio State University I. Introduction On August 30, 2023, the US Department of Health and Human Services (HHS) concluded a scheduling review of psychoactive cannabis and recommended that the Drug Enforcement Administration (DEA) “re-schedule” psychoactive cannabis (i.e., cannabis that doesn’t qualify as “hemp” also known as “marijuana” and parts of the cannabis plant with more than 0.3% Delta-9 THC) from Schedule I to Schedule III…